Women faced with the prospect of a cancer diagnosis have many life-changing concerns and decisions in front of them. With the diagnosis of breast cancer, in particular, women have the knowledge there is a distinct chance that they will lose their breasts in the course of the treatment. Additionally, women know that during chemotherapy, they will temporarily lose their hair. Both of those things are devastating for women, as both are part of being a female. However, the attorneys of NGK Law are investigating one of the chemotherapy drugs used to treat breast cancer called Taxotere. Recent studies have indicated that in 3% to 6% of the women that use Taxotere instead of other chemotherapy drugs, the hair loss becomes permanent.
What makes this so devastating is that the manufacturer of Taxotere, Sanofi Aventis, failed to warn women of the risk of permanent hair loss. Women, particularly, with Stage I or Stage II breast cancer, which has a high rate of being cured, are often presented with several options for the chemotherapy. If given the option between one chemotherapy drug that does not cause permanent baldness, and another, Taxotere, that does cause permanent baldness, it stands to reason that none of these women would choose the drug that causes permanent baldness. Unfortunately, the manufacturers of Taxotere failed to provide the cancer-stricken women with this information prior to making their decision.
The American Cancer Society estimates that approximately 246,660 new cases of breast cancer are diagnosed every year. A large percentage of these women undergo chemotherapy as part of the treatment process. Of those, Taxotere is one of the most chemotherapy options. As a result, there are potentially thousands of women that have been inflicted with permanent baldness as a result of being given Taxotere rather than another, more safe alternative.
NGK Law is handling lawsuits for women that are suffering permanent baldness after undergoing chemotherapy for breast cancer. If you or a loved one is suffering from permanent baldness and underwent chemotherapy for breast cancer, please contact the experienced pharmaceutical and medical device attorneys at NGK Law at 314-241-1919 or 844-564-5529 to discuss the options available to you. We have helped thousands of people injured by dangerous pharmaceutical drugs and medical devices, and we welcome the opportunity to assist you.